Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KDM5A | P29375 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | UBE2M | P61081 | 1/20 | 0.30 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25975699 | 0.81 | CNR1 (0.35) | CNR1CNR2POLBKDM5AHTR1A | |
| SCHEMBL27910677 | 0.79 | POLB (0.50) | CNR1CNR2POLB | |
| SCHEMBL17610321 | 0.78 | CNR1 (0.34) | CNR1CNR2POLBKDM5AHTR1A | |
| SCHEMBL26388630 | 0.77 | POLB (0.34) | POLB | |
| SCHEMBL25414795 | 0.74 | LRRK2 (0.40) | CNR1CNR2POLB | |
| SCHEMBL19504916 | 0.74 | — | — | |
| SCHEMBL30200311 | 0.69 | — | — | |
| SCHEMBL24896879 | 0.69 | LRRK2 (0.30) | — | |
| SCHEMBL22538714 | 0.68 | GLS (0.35) | HTR1AHTR7 | |
| SCHEMBL1799691 | 0.68 | CNR1 (0.35) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023154282-A1 | COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS | THERAS, INC. (US) | 2023-08-17 | — | — | WO | disclosed |